Yi-Xin Wang

President chez Crown Bioscience North Carolina

Profil

Yi-Xin Wang is currently employed as the SVP-Cardiovascular & Metabolic Diseases Research at Crown Bioscience, Inc. and as the President at Crown Bioscience North Carolina.
Previously, Dr. Wang held positions such as Pharmacology Director at Arête Therapeutics, Inc., President & Director at PreClinOmics, Inc., and Principal at Berlex, Inc., Bayer Schering Pharma AG, Hoffman-LaRoche F & Co. AG, Bayer HealthCare Pharmaceuticals, Inc., and GlaxoSmithKline LLC.
Dr. Wang also worked as a Senior Scientist at Roche Pharmaceuticals, Inc. and as a Professor and Assistant Professor at the University of Tennessee.
Dr. Wang received graduate and doctorate degrees from Shanghai Jiao Tong University.

Postes actifs de Yi-Xin Wang

Sociétés	Poste	Début
Crown Bioscience, Inc.	Corporate Officer/Principal	01/07/2010
Crown Bioscience North Carolina	President	-

Anciens postes connus de Yi-Xin Wang

Sociétés	Poste	Fin
Arête Therapeutics, Inc.	Corporate Officer/Principal	01/01/2009
GlaxoSmithKline LLC	Corporate Officer/Principal	01/01/2008
BAYER AG	Corporate Officer/Principal	01/01/2008
University of Tennessee	Corporate Officer/Principal	01/01/1996
PreClinOmics, Inc.	President	-